Oram Jeffrey 4
4 · Alzamend Neuro, Inc. · Filed Sep 15, 2021
Insider Transaction Report
Form 4
Oram Jeffrey
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-13+2,778→ 2,778 total - Exercise/Conversion
Restricted Stock Grant
2021-09-13−2,778→ 97,222 totalExp: 2024-09-13→ Common Stock (2,778 underlying)
Footnotes (3)
- [F1]Represents the vesting of restricted stock.
- [F2]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
- [F3]The restricted stock grant vests in 36 equal monthly installments commencing on September 13, 2021.